3SBio IPO: Chinese Biotech Success
3SBio Inc. (SSRX-NASDAQ) opened at a premium to its pricing out of the chute today. The company priced 7.7 million ADR shares at $16.00, and the first print was $17.50. The original range was…
3SBio Inc. (SSRX-NASDAQ) opened at a premium to its pricing out of the chute today. The company priced 7.7 million ADR shares at $16.00, and the first print was $17.50. The original range was…
From BioHealth Investor Biotechnology XOMA LTD +11.15% DYADIC INTERNATIONAL +9.27% ADVENTRX PHARMACTL +6.01% VION PHARM INC +5.63% GENVEC INC +5.61% Diagnostic Substances NYMOX PHARM CORP +15.67% EPICEPT CORPORATION +9.29% THRESHOLD PHARMACEUT +3.15% ABAXIS INC…
by H.S. AyoubBioHealth Investor.com On Tuesday Thermogenesis Corp (KOOL) announced that it had submitted the necessary paperwork answering certain questions the FDA had regarding its pre-market approval application for the CryoSeal Fibrin Sealant System.…
From BioHealth Investor Biotechnology HEMOBIOTECH INC +9.52% AFFYMAX, INC. +7.03% OSIRIS THERAPEUTICS +6.93% IDM PHARMA INC +6.53% 0 BIOCRYST PHARM INC +6.23% Diagnostic Substances GENELABS TECH INC +6.00% PONIARD PHARMA +5.57% AVALON PHARMACEUTIC +4.16%…
by H.S. AyoubBioHealth Investor.com According to the Financial Times, last month the Indonesian government stopped sharing key samples of H5N1 avian flu virus with international laboratories and researchers pending a planned collaboration with pharmaceutical…
From BioHealth Investor Biotechnology SEATTLE GENETICS I +11.38% IMMUNOGEN INC +8.86% IDM PHARMA INC +8.58% SUNESIS PHARMACEUTIC +8.55% SANGAMO BIOSCIENCE +8.52% Diagnostic Substances NYMOX PHARM CORP +44.72% VALERA PHARMACEUTICA +6.03% HEALTHCARE TECH LTD +5.33%…
by H.S. AyoubBioHealth Investor.com I first mentioned Access Pharmaceuticals (ACCP.OB) way back in October after the company’s shares doubled on 16x average volume with no news. On Friday, shares of Access Pharmaceuticals jumped again,…
From BioHealth Investor The following list represents the top ten medical stocks ranked according to Earnings Per Share and Relative Strength by Investor’s Business Daily (2/03/06) scores out of 100 (last week’s rank, change…
by Adam Rubenstein Claros Diagnostics (Woburn, MA) is developing a handheld disease monitoring device that allows anyone to perform laboratory-quality blood tests in any setting, has closed a $7.8M Series A financing. The round…
Biotechnology SEATTLE GENETICS I +15.33% GILEAD SCIENCES +11.21% CHELSEA THERAPEUTICS +11.01% SGX PHARMACEUTICALS +9.41% IDM PHARMA INC +9.39% Diagnostic Substances RG GLBL LIFESTYLS +12.50% SYNOVICS PHARMACEUTL +7.14% IMMUNOMEDICS INC +7.07% GENE LOGIC INC +6.06%…
by Andrew Vaino According to Greek mythology, after displeasing the gods, Sisyphus was consigned to spend eternity rolling a heavy stone up a steep hill and then watching as it rolled back down. He…
by Adam Rubenstein Lot’s of action transpiring at Allos Therapeutics (ALTH) since Paul Berns has taken over the reigns. We should expect a $50.5M financing to close tomorrow courtesy of Merrill, where 9M shares…
From BioHealth Investor Biotechnology IDERA PHARMACEUTICAL +9.90% BIONOVO INC +9.20% CHELSEA THERAPEUTICS +9.00% CURIS INC +7.58% MICROMET INC +5.78% Diagnostic Substances PALATIN TECH INC +13.66% AVALON PHARMACEUTIC +9.30% SURMODICS INC +7.99% SYNOVICS PHARMACEUTL +7.69%…
by H.S. AyoubBioHealth Investor.com Shares of Canadian firm Polydex Pharmaceuticals (POLYXF) absolutely sank more than 50% on Wednesday as the company announced that phase III trials of Ushercell, a topical microbicide gel for the…
From BioHealth Investor Biotechnology PIPEX PHARMACEUTICAL +42.50% BIONOVO INC +15.87% NEUROBIOLOGICAL TECH +13.93% REPROS THERAPEUTICS +10.24% OBAGI MEDICAL +9.90% Diagnostic Substances LEXICON GENETICS I +8.50% GENELABS TECH INC +6.21% EZ EM INC +5.59% SURMODICS…